New hormone receptor-positive breast cancer mouse cell line mimicking the immune microenvironment of anti-PD-1 resistant mammary carcinoma
Background Progress in breast cancer (BC) research relies on the availability of suitable cell lines that can be implanted in immunocompetent laboratory mice. The best studied mouse strain, C57BL/6, is also the only one for which multiple genetic variants are available to facilitate the exploration...
Main Authors: | Carlos Lopez-Otin, Christophe Klein, Chantal Desdouets, Guido Kroemer, Pierre Laurent-Puig, Jonathan Pol, Sophie Mouillet-Richard, Gautier Stoll, Isabelle Martins, Maria Perez-Lanzon, Vincent Carbonnier, Pierre Cordier, Fatima Domenica Elisa De Palma, Adriana Petrazzuolo, Floriane Arbaretaz, Khady Mangane, Helene Fohrer Ting, Juliette Paillet, Delphine Le Corre, Wenjjin Xiao, Marine Sroussi, Maria Chiara Maiuri |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-06-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/11/6/e007117.full |
Similar Items
-
Mammary carcinoma: toward a realistic mouse model of incurable cancers
by: Maria Pérez-Lanzón, et al.
Published: (2023-12-01) -
Pharmacological inhibitors of anaplastic lymphoma kinase (ALK) induce immunogenic cell death through on-target effects
by: Adriana Petrazzuolo, et al.
Published: (2021-07-01) -
Beneficial autoimmunity and maladaptive inflammation shape epidemiological links between cancer and immune-inflammatory diseases
by: Jonathan Pol, et al.
Published: (2022-12-01) -
Downregulation of mitochondrial complex I induces ROS production in colorectal cancer subtypes that differently controls migration
by: Jean Bastin, et al.
Published: (2023-08-01) -
Autophagy represses hepatic carcinogenesis
by: Juliette Paillet, et al.
Published: (2019-07-01)